Summary

The Global Lipid Nutrition (Nutritional Lipids) Market is valued at approximately USD 6.37 billion in 2024 and is poised to grow at a remarkable CAGR of 8.11% over the forecast period 2025–2035. Lipid nutrition, once an understated component of dietary science, is now emerging as a vital pillar of preventive healthcare and optimal well-being. These nutritional lipids, including Omega-3 and Omega-6 fatty acids, are being embraced across multiple consumer segments—from infants requiring neural development support to adults managing cardiovascular and metabolic health. Driven by the global pivot toward preventive wellness and functional foods, lipid nutrition has secured its place at the heart of food science innovation. As consumers and regulators increasingly scrutinize product labels, lipid formulations that deliver clean, science-backed benefits have become indispensable assets in the portfolios of forward-thinking food and nutraceutical brands.
Heightened awareness surrounding the critical role of essential fatty acids in brain development, immune modulation, and anti-inflammatory mechanisms has substantially uplifted demand across both developed and emerging economies. Omega-3, in particular, has transitioned from niche supplement aisles into mainstream products such as dairy alternatives, protein powders, and functional beverages. According to various market studies, growing cases of lifestyle disorders and rising health literacy among millennial and Gen Z populations are accelerating adoption rates. Meanwhile, industry players are stepping up R&D initiatives to encapsulate lipids in highly bioavailable forms, addressing solubility challenges and enhancing integration into various delivery platforms such as gummies, powdered blends, and ready-to-drink formats. Infant formula enriched with Omega-3s, for instance, is witnessing unprecedented growth as parents actively seek science-based nutrition for early-stage cognitive and visual development.
Regionally, North America continues to assert dominance owing to its sophisticated dietary supplement landscape, high disposable income, and robust healthcare awareness. The U.S., in particular, has seen explosive growth in personalized nutrition plans that incorporate lipid-based regimens. In Europe, stringent food safety regulations and the EFSA’s endorsement of certain lipid benefits have bolstered market credibility, encouraging manufacturers to reformulate products around proven fatty acid profiles. On the other hand, Asia Pacific is expected to witness the fastest growth rate throughout the forecast period, fueled by increasing birth rates, a growing elderly population, and rapid urbanization. Countries such as China, India, and Japan are rapidly transitioning toward fortified and functional food habits, especially in the wake of post-pandemic health consciousness. Moreover, regional investments in marine-based lipid extraction and algae-derived Omega-3 sources are catalyzing innovation tailored to local dietary preferences and sustainability mandates.
Major market player included in this report are:
• BASF SE
• Cargill, Incorporated
• Croda International Plc.
• Koninklijke DSM N.V.
• Archer Daniels Midland Company
• Nordic Naturals, Inc.
• Kerry Group plc
• Corbion N.V.
• Stepan Company
• Neptune Wellness Solutions Inc.
• Pharma Marine AS
• Denomega Nutritional Oils
• Aker BioMarine ASA
• Lonza Group AG
• Wilmar International Limited
Global Lipid Nutrition (Nutritional Lipids) Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope – Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Type:
• Omega-3
• Omega-6
By Application:
• Infant Formula
• Dietary Supplements
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1. Global Lipid Nutrition (Nutritional Lipids) Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
 1.2.1. Forecast Model
 1.2.2. Desk Research
 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
 1.4.1. Market Definition
 1.4.2. Market Segmentation
1.5. Research Assumption
 1.5.1. Inclusion & Exclusion
 1.5.2. Limitations
 1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Lipid Nutrition (Nutritional Lipids) Market Forces Analysis (2024–2035)
3.1. Market Forces Shaping the Global Lipid Nutrition (Nutritional Lipids) Market
3.2. Drivers
 3.2.1. Rising consumer awareness toward preventive healthcare and wellness
 3.2.2. Increasing demand for fortified and functional food products
3.3. Restraints
 3.3.1. High production costs of bioavailable lipid formulations
 3.3.2. Regulatory complexities for ingredient approvals
3.4. Opportunities
 3.4.1. Technological advancements in lipid encapsulation and delivery systems
 3.4.2. Growing applications in infant formula and personalized nutrition
Chapter 4. Global Lipid Nutrition (Nutritional Lipids) Industry Analysis
4.1. Porter’s 5 Forces Model
 4.1.1. Bargaining Power of Buyer
 4.1.2. Bargaining Power of Supplier
 4.1.3. Threat of New Entrants
 4.1.4. Threat of Substitutes
 4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024–2035)
4.3. PESTEL Analysis
 4.3.1. Political
 4.3.2. Economical
 4.3.3. Social
 4.3.4. Technological
 4.3.5. Environmental
 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024–2025)
4.7. Global Pricing Analysis and Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Lipid Nutrition (Nutritional Lipids) Market Size & Forecasts by Type 2025–2035
5.1. Market Overview
5.2. Global Lipid Nutrition Market Performance - Potential Analysis (2025)
5.3. Omega-3
 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 5.3.2. Market Size Analysis, by Region, 2025–2035
5.4. Omega-6
 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 5.4.2. Market Size Analysis, by Region, 2025–2035
Chapter 6. Global Lipid Nutrition (Nutritional Lipids) Market Size & Forecasts by Application 2025–2035
6.1. Market Overview
6.2. Global Lipid Nutrition Market Performance - Potential Analysis (2025)
6.3. Infant Formula
 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 6.3.2. Market Size Analysis, by Region, 2025–2035
6.4. Dietary Supplements
 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 6.4.2. Market Size Analysis, by Region, 2025–2035
Chapter 7. Global Lipid Nutrition (Nutritional Lipids) Market Size & Forecasts by Region 2025–2035
7.1. Lipid Nutrition Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Lipid Nutrition Market
 7.3.1. U.S. Lipid Nutrition Market
  7.3.1.1. Type Breakdown Size & Forecasts, 2025–2035
  7.3.1.2. Application Breakdown Size & Forecasts, 2025–2035
 7.3.2. Canada Lipid Nutrition Market
  7.3.2.1. Type Breakdown Size & Forecasts, 2025–2035
  7.3.2.2. Application Breakdown Size & Forecasts, 2025–2035
7.4. Europe Lipid Nutrition Market
 7.4.1. UK Lipid Nutrition Market
  7.4.1.1. Type Breakdown Size & Forecasts, 2025–2035
  7.4.1.2. Application Breakdown Size & Forecasts, 2025–2035
 7.4.2. Germany Lipid Nutrition Market
  7.4.2.1. Type Breakdown Size & Forecasts, 2025–2035
  7.4.2.2. Application Breakdown Size & Forecasts, 2025–2035
 7.4.3. France Lipid Nutrition Market
  7.4.3.1. Type Breakdown Size & Forecasts, 2025–2035
  7.4.3.2. Application Breakdown Size & Forecasts, 2025–2035
 7.4.4. Spain Lipid Nutrition Market
  7.4.4.1. Type Breakdown Size & Forecasts, 2025–2035
  7.4.4.2. Application Breakdown Size & Forecasts, 2025–2035
 7.4.5. Italy Lipid Nutrition Market
  7.4.5.1. Type Breakdown Size & Forecasts, 2025–2035
  7.4.5.2. Application Breakdown Size & Forecasts, 2025–2035
 7.4.6. Rest of Europe Lipid Nutrition Market
  7.4.6.1. Type Breakdown Size & Forecasts, 2025–2035
  7.4.6.2. Application Breakdown Size & Forecasts, 2025–2035
7.5. Asia Pacific Lipid Nutrition Market
 7.5.1. China Lipid Nutrition Market
  7.5.1.1. Type Breakdown Size & Forecasts, 2025–2035
  7.5.1.2. Application Breakdown Size & Forecasts, 2025–2035
 7.5.2. India Lipid Nutrition Market
  7.5.2.1. Type Breakdown Size & Forecasts, 2025–2035
  7.5.2.2. Application Breakdown Size & Forecasts, 2025–2035
 7.5.3. Japan Lipid Nutrition Market
  7.5.3.1. Type Breakdown Size & Forecasts, 2025–2035
  7.5.3.2. Application Breakdown Size & Forecasts, 2025–2035
 7.5.4. Australia Lipid Nutrition Market
  7.5.4.1. Type Breakdown Size & Forecasts, 2025–2035
  7.5.4.2. Application Breakdown Size & Forecasts, 2025–2035
 7.5.5. South Korea Lipid Nutrition Market
  7.5.5.1. Type Breakdown Size & Forecasts, 2025–2035
  7.5.5.2. Application Breakdown Size & Forecasts, 2025–2035
 7.5.6. Rest of APAC Lipid Nutrition Market
  7.5.6.1. Type Breakdown Size & Forecasts, 2025–2035
  7.5.6.2. Application Breakdown Size & Forecasts, 2025–2035
7.6. Latin America Lipid Nutrition Market
 7.6.1. Brazil Lipid Nutrition Market
  7.6.1.1. Type Breakdown Size & Forecasts, 2025–2035
  7.6.1.2. Application Breakdown Size & Forecasts, 2025–2035
 7.6.2. Mexico Lipid Nutrition Market
  7.6.2.1. Type Breakdown Size & Forecasts, 2025–2035
  7.6.2.2. Application Breakdown Size & Forecasts, 2025–2035
7.7. Middle East and Africa Lipid Nutrition Market
 7.7.1. UAE Lipid Nutrition Market
  7.7.1.1. Type Breakdown Size & Forecasts, 2025–2035
  7.7.1.2. Application Breakdown Size & Forecasts, 2025–2035
 7.7.2. Saudi Arabia Lipid Nutrition Market
  7.7.2.1. Type Breakdown Size & Forecasts, 2025–2035
  7.7.2.2. Application Breakdown Size & Forecasts, 2025–2035
 7.7.3. South Africa Lipid Nutrition Market
  7.7.3.1. Type Breakdown Size & Forecasts, 2025–2035
  7.7.3.2. Application Breakdown Size & Forecasts, 2025–2035
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. BASF SE
 8.2.1. Company Overview
 8.2.2. Key Executives
 8.2.3. Company Snapshot
 8.2.4. Financial Performance (Subject to Data Availability)
 8.2.5. Product/Services Port
 8.2.6. Recent Development
 8.2.7. Market Strategies
 8.2.8. SWOT Analysis
8.3. Cargill, Incorporated
8.4. Croda International Plc.
8.5. Koninklijke DSM N.V.
8.6. Archer Daniels Midland Company
8.7. Nordic Naturals, Inc.
8.8. Kerry Group plc
8.9. Corbion N.V.
8.10. Stepan Company
8.11. Neptune Wellness Solutions Inc.
8.12. Pharma Marine AS
8.13. Denomega Nutritional Oils
8.14. Aker BioMarine ASA
8.15. Lonza Group AG
8.16. Wilmar International Limited